Patent Assignment
Reel/Frame 026082/0230
Corrective Assignment to Correct the Identification of the True Assignee Previously Recorded on Reel 025952 Frame 0559. Assignor(S) Hereby Confirms the Entire Right, Title & Interest for the Us, as Are Identified in Attached Schedule a, Including All Rights to Claim Priority.
Recorded: 2011-04-06
Pages: 13
Assignor
WYETH
Executed: 2011-03-09
Assignee
LIGAND PHARMACEUTICALS INCORPORATED
11085 NORTH TORREY PINES ROAD, SUITE 300, LA JOLLA, CALIFORNIA, 92037
Covered Properties
(14)
Cyclocarbamate and cyclic amide derivatives
Patent:
6,306,851 →
Application:
09/552,036 →
Cyclic Regimens Using Cyclic Urea and Cyclic Amide Derivatives
Patent:
6,399,593 →
Application:
09/552,037 →
Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
Patent:
6,319,912 →
Application:
09/552,038 →
Combination Regimens Using Progesterone Receptor Modulators
Patent:
6,444,668 →
Application:
09/552,350 →
Cyclic Regimens Using Quinazolinone and Benzoxazine Derivatives
Patent:
6,498,154 →
Application:
09/552,357 →
Cyclic Contraceptive Regimens Using Cyclocarbamate and Cyclic Amide Derivatives
Patent:
6,380,178 →
Application:
09/552,545 →
Benzimidazolones and Analogues
Patent:
6,380,235 →
Application:
09/552,546 →
Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
Patent:
6,358,948 →
Application:
09/552,629 →
Cyclocarbamate and Cyclic Amide Derivatives
Combination Regimens Using 3,3-Substituted Indoline Derivatives
1,2,3,4-Tetrahydro-2-Thioxo-Quinolinyl and 1,2,3,4-Tetrahydro-2-Oxo-Quinolinyl Derivatives as Progesterone Receptor Modulators
Contraceptive Methods Using Benzimidazolones
3,3-Substituted Indoline Derivatives
Combination Regimens Using Progesterone Receptor Modulators
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.